
|Articles|October 16, 2020
Direct Analysis of In-Process Oligonucleotides Without Manual Purification
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
3
Accelerate Your Biologic with HEK Cell Lines
4